Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGF 165 (Active) Protéine

Origine: Humain Hôte: Escherichia coli (E. coli) Recombinant < 98 % by SDS-PAGE gel and HPLC analyses. Active
N° du produit ABIN2469208
  • Antigène
    VEGF 165
    Type de proteíne
    Recombinant
    Activité biologique
    Active
    Origine
    • 18
    • 3
    • 2
    Humain
    Source
    • 11
    • 7
    • 1
    • 1
    • 1
    • 1
    • 1
    Escherichia coli (E. coli)
    Séquence
    APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR
    Attributs du produit
    Biological activity was determined by the dose - dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 1.0 - 8.0 ng/mL.
    Pureté
    < 98 % by SDS-PAGE gel and HPLC analyses.
    niveau d'endotoxine
    Endotoxin level is less than 0.1 ng per μg (1 EU/μg).
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Conseil sur la manipulation
    As with any protein, exposing VEGF165 recombinant protein to repeated freeze / thaw cycles is not recommended. When working with proteins care should be taken to keep recombinant protein at a cool and stable temperature.
    Stock
    -20 °C
    Stockage commentaire
    The recombinant protein is stable for at least 2 years from date of receipt at -20 °C. Reconstituted VEGF165 is stable for at least 3 months when stored in working aliquots with a carrier protein at -20 °C.
    Date de péremption
    24 months
  • Antigène
    VEGF 165
    Autre désignation
    VEGF165
    Sujet
    VEGF is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability. Expressed in vascularized tissues, VEGF plays a prominent role in normal and pathological angiogenesis. Substantial evidence implicates VEGF in the induction of tumor metastasis and intra-ocular neovascular syndromes. VEGF signals through the three receptors , fms-like tyrosine kinase (flt-1), KDR gene product (the murine homolog of KDR is the flk-1 gene product) and the flt4 gene product. Recombinant human VEGF165 is a 38.2 kDa disulfide-linked homodimeric protein consisting of two 165 amino acid polypeptide chains.
    ID gène
    7422
    NCBI Accession
    NP_001028928
    OMIM
    76781487
Vous êtes ici:
Support technique